Q1 2026 saw a sharp decline in revenue and profit due to one-off items and the Apitare sale, with the year expected to be transitional as the company reorganizes and divests its fund management business. The equity ratio improved, and a growing dividend was approved.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.